Drug intelligence / Profile preview

mogroside v

Development stage
Preclinical
Modality
Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Oral
01

Overview

Mogroside V is a natural cucurbitane glycoside and triterpenoid isolated from the fruit of Siraitia grosvenorii (monk fruit). It is intensely sweet—about 250 times sweeter than sucrose—and is widely used as a low-calorie natural sweetener in foods and beverages[1][3][5]. Mogroside V exhibits antioxidant properties and has demonstrated anti-inflammatory, anti-diabetic, and anti-carcinogenic effects in preclinical studies[1][5][7]. In cancer models, it inhibits tumor growth by promoting apoptosis and cell cycle arrest in pancreatic cancer cells as well as inhibiting angiogenesis[1][5]. Recent research also suggests neuroprotective effects; mogroside V can mitigate neurotoxicity and dopaminergic neuron loss in Parkinson’s disease models by restoring metabolic balance in affected brain regions[2]. Its mechanisms include modulation of oxidative stress pathways (e.g. inhibition of COX-2 expression/ROS production) but do not involve direct action on classic drug targets. Mogroside V is primarily developed for use as a food additive or dietary supplement rather than as a pharmaceutical drug.

Other names
MGV88901-36-4ZFF6Z51TURZFF-6Z51TURZFF 6Z51TURUNII-ZFF6Z51TURUNII-ZFF-6Z51TURUNII-ZFF 6Z51TURMOGROSIDE V USP-RS
02

Targets

VEGFA (Vascular endothelial growth factor A)ADRB2 (β2)TAS2R16 (Taste receptor type 2 member 16)TAS2R38 (Taste receptor type 2 member 38)

Beyond the preview

Go deeper on mogroside v.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mogroside v.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call